Hennion & Walsh Asset Management’s Applied Therapeutics APLT Stock Holding History

Hennion & Walsh Asset Management’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-327,137	Closed	-$32.7K	–	933
2025 Q4	$32.7K	Buy	327,137 +44,289	+16%	+$28.1K	﹤0.01%	926
2025 Q3	$171K	Sell	282,848 -5,150	-2%	-$2.43K	0.01%	925
2025 Q2	$89.6K	Sell	287,998 -13,305	-4%	-$5.15K	﹤0.01%	912
2025 Q1	$147K	Sell	301,303 -12,052	-4%	-$7.1K	0.01%	848
2024 Q4	$268K	Buy	313,355 +47,983	+18%	+$301K	0.01%	785
2024 Q3	$2.26M	Buy	265,372 +68,330	+35%	+$403K	0.11%	251
2024 Q2	$920K	Buy	+197,042	New	+$932K	0.05%	444

Hennion & Walsh Asset Management's APLT Position: Q1 2026 in Review

Hennion & Walsh Asset Management sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 327,137 shares — an estimated $32.7K sold.

Hennion & Walsh Asset Management first reported a position in APLT in Q2 2024 and held it in 7 quarters. The position peaked at $2.26M in Q3 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

Hennion & Walsh Asset Management reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
Hennion & Walsh Asset Management sold 327,137 Applied Therapeutics shares in Q1 2026, an estimated $32.7K.
Hennion & Walsh Asset Management first reported a position in Applied Therapeutics in Q2 2024 and held it in 7 quarters.
Hennion & Walsh Asset Management's Applied Therapeutics position peaked at $2.26M in Q3 2024.
0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q1 2026, filed 13 May 2026.